Enzyme replacement therapy in Fabry disease: towards a better understanding of the implications of antibody formation and dose.
C E M
CE
Hollak
A C
AC
Vedder
B
B
Winchester
J M F G
JM
Aerts
F
F
Breunig
D000917:Antibody Formation; D001691:Biological Therapy; D004305:Dose-Response Relationship, Drug; D000795:Fabry Disease / Q000201:enzymology / Q000276:immunology* / Q000628:therapy*; D005260:Female; D005696:Galactosidases / Q000008:administration & dosage* / Q000276:immunology* / Q000378:metabolism; D006801:Humans; D008297:Male
D005696:Galactosidases